| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| G0483 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed |
12,772 |
6,773 |
$2.61M |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
18,155 |
8,206 |
$1.03M |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
9,859 |
5,742 |
$721K |
| G0659 |
Drug test(s), definitive, utilizing drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem), excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase), performed without method or drug-specific calibration, without matrix-matched quality control material, or without use of stable isotope or other universally recognized internal standard(s) for each drug, drug metabolite or drug class per specimen; qualitative or quantitative, all sources, includes specimen validity testing, per day, any number of drug classes |
8,786 |
3,267 |
$702K |
| T2023 |
Targeted case management; per month |
2,751 |
1,939 |
$477K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
13,463 |
10,778 |
$459K |
| H0038 |
Self-help/peer services, per 15 minutes |
16,392 |
7,869 |
$269K |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
12,919 |
9,785 |
$192K |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
2,069 |
1,335 |
$172K |
| T1007 |
Alcohol and/or substance abuse services, treatment plan development and/or modification |
2,140 |
1,797 |
$88K |
| 80306 |
|
5,194 |
3,552 |
$75K |
| 90791 |
Psychiatric diagnostic evaluation |
724 |
683 |
$68K |
| 90837 |
Psychotherapy, 53 minutes with patient |
813 |
557 |
$50K |
| H0002 |
Behavioral health screening to determine eligibility for admission to treatment program |
986 |
788 |
$37K |
| 90832 |
Psychotherapy, 30 minutes with patient |
985 |
709 |
$30K |
| 81025 |
|
3,358 |
2,467 |
$14K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
198 |
186 |
$12K |
| H0015 |
Alcohol and/or drug services; intensive outpatient (treatment program that operates at least 3 hours/day and at least 3 days/week and is based on an individualized treatment plan), including assessment, counseling; crisis intervention, and activity therapies or education |
118 |
16 |
$10K |
| G0482 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed |
1,125 |
503 |
$10K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
108 |
87 |
$8K |
| H0001 |
Alcohol and/or drug assessment |
108 |
77 |
$2K |
| 99406 |
|
300 |
283 |
$2K |
| 80305 |
|
128 |
100 |
$2K |
| S9446 |
Patient education, not otherwise classified, non-physician provider, group, per session |
183 |
124 |
$235.00 |
| 36415 |
Collection of venous blood by venipuncture |
69 |
69 |
$13.45 |